These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 9765203)

  • 1. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling.
    Lin AW; Barradas M; Stone JC; van Aelst L; Serrano M; Lowe SW
    Genes Dev; 1998 Oct; 12(19):3008-19. PubMed ID: 9765203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence.
    Wang W; Chen JX; Liao R; Deng Q; Zhou JJ; Huang S; Sun P
    Mol Cell Biol; 2002 May; 22(10):3389-403. PubMed ID: 11971971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senescence of human fibroblasts induced by oncogenic Raf.
    Zhu J; Woods D; McMahon M; Bishop JM
    Genes Dev; 1998 Oct; 12(19):2997-3007. PubMed ID: 9765202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic ras and p53 cooperate to induce cellular senescence.
    Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
    Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
    Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
    Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability.
    Fukasawa K; Vande Woude GF
    Mol Cell Biol; 1997 Jan; 17(1):506-18. PubMed ID: 8972231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts.
    Deng Q; Liao R; Wu BL; Sun P
    J Biol Chem; 2004 Jan; 279(2):1050-9. PubMed ID: 14593117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
    Sebastian T; Johnson PF
    Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replicative senescence of human fibroblasts: the role of Ras-dependent signaling and oxidative stress.
    Hütter E; Unterluggauer H; Uberall F; Schramek H; Jansen-Dürr P
    Exp Gerontol; 2002; 37(10-11):1165-74. PubMed ID: 12470828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
    Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ
    Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F; Bonnec G; Tardivel A; Boujard D
    Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.
    Serrano M; Lin AW; McCurrach ME; Beach D; Lowe SW
    Cell; 1997 Mar; 88(5):593-602. PubMed ID: 9054499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a.
    Bulavin DV; Kovalsky O; Hollander MC; Fornace AJ
    Mol Cell Biol; 2003 Jun; 23(11):3859-71. PubMed ID: 12748288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual role of MEK/ERK signaling in senescence and transformation of intestinal epithelial cells.
    Boucher MJ; Jean D; Vézina A; Rivard N
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G736-46. PubMed ID: 14701721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of BCR- and PKC/Ca(2+)-mediated activation of the Raf1/MEK/MAPK pathway by protein-tyrosine kinase and -tyrosine phosphatase activities.
    Kawauchi K; Lazarus AH; Sanghera JS; Man GL; Pelech SL; Delovitch TL
    Mol Immunol; 1996 Feb; 33(3):287-96. PubMed ID: 8649450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence.
    Kortum RL; Johnson HJ; Costanzo DL; Volle DJ; Razidlo GL; Fusello AM; Shaw AS; Lewis RE
    Mol Cell Biol; 2006 Mar; 26(6):2202-14. PubMed ID: 16507997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling.
    Morgan MA; Dolp O; Reuter CW
    Blood; 2001 Mar; 97(6):1823-34. PubMed ID: 11238126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p38 pathway provides negative feedback for Ras proliferative signaling.
    Chen G; Hitomi M; Han J; Stacey DW
    J Biol Chem; 2000 Dec; 275(50):38973-80. PubMed ID: 10978313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related reductions in the activation of mitogen-activated protein kinases p44mapk/ERK1 and p42mapk/ERK2 in human T cells stimulated via ligation of the T cell receptor complex.
    Whisler RL; Newhouse YG; Bagenstose SE
    Cell Immunol; 1996 Mar; 168(2):201-10. PubMed ID: 8640866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.